RPRuzanna R. Parsamyan

Ruzanna R. Parsamyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ruzanna R. Parsamyan has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Age-Associated Changes in Connective Tissue and Decline in Physical Function: Potential for Nutritional Intervention within the Concept of Active Longevity. A Review

    by A.P. Rachin, L.S. Chutko, S.M. Karpov, S.A. Rachin, D.YU. Butko, M.N. Sharov, R.R. Parsamyan, L.V. Shcheglova, A.YU. Doroginina

    RELEVANCE. Increasing life expectancy is accompanied by a growing prevalence of age-associated conditions that impair mobility and functional independence. Contemporary healthy-ageing concepts focus not only on survival and disease burden but primarily on preservation of functional ability. Age-related changes in skeletal muscle and extracellular matrix, tendons and ligaments, articular cartilage, and bone are important determinants of physical decline. Altered collagen remodelling, accumulation of advanced glycation end-products, cellular senescence, changes in extracellular-matrix mechanics, sarcopenia, and osteoarthritis form an interconnected pathophysiological continuum. AIM. To summarize current evidence on age-associated changes in connective tissue and their relationship with physical-function decline and to evaluate the potential role of nutritional support, including protein, amino acids, collagen peptides, and relevant cofactors, within an active-longevity strategy. MATERIALS AND METHODS. A narrative review with a structured literature search was performed using PubMed/MEDLINE and relevant international health-organization materials published between January 2021 and August 2026. Priority was given to systematic reviews, meta-analyses, randomized controlled trials, and studies addressing healthy ageing, intrinsic capacity, sarcopenia, extracellular matrix, tendon ageing, osteoarthritis, dietary protein, collagen peptides, vitamin C, glucosamine, and chondroitin. The composition of the multicomponent collagen complex Spocolla was additionally analysed using the product materials provided by the manufacturer. RESULTS AND DISCUSSION. Age-related physical decline is a multifactorial process involving both neuromuscular impairment and extracellular-matrix remodelling. Current evidence most consistently supports adequate protein intake and combination of nutritional interventions with resistance exercise. Recent meta-analyses also indicate potentially clinically relevant effects of collagen derivatives on pain and function in osteoarthritis and possible benefits of collagen peptides combined with exercise for selected measures of fatfree mass, musculotendinous remodelling, and strength. A multicomponent strategy combining collagen peptides with vitamin C and other nutritionally relevant compounds may therefore be of interest. Spocolla represents an example of such a formulation, combining multiple collagen sources, vitamin C, glucosamine, chondroitin, and branched-chain amino acids in a ready-to-use gel formulation. CONCLUSION. Connective tissue should be considered an integral component of the muscle–tendon–joint functional system within active-longevity strategies. Nutritional support may complement, but not replace, adequate diet, exercise, rehabilitation, and treatment of underlying musculoskeletal disease. Multicomponent collagen formulations are mechanistically attractive, although product-specific randomized trials in older populations remain necessary. KEYWORDS: active longevity, healthy ageing, connective tissue, collagen, extracellular matrix, sarcopenia, physical function, mobility, osteoarthritis, nutritional support, collagen peptides, Spocolla

  • Chronic Cerebral Ischemia: Current Perspectives and Neurometabolic Therapy. A Review

    by A.P. Rachin, L.S. Chutko, S.M. Karpov, S.A. Rachin, D.YU. Butko, M.N. Sharov, R.R. Parsamyan, L.V. Shcheglova

    RELEVANCE. Chronic cerebral ischemia is currently regarded as a clinical and radiological phenotype of cerebral small vessel disease, characterized by progressive white matter damage, formation of lacunar infarcts, and disruption of subcortical-frontal connections, leading to cognitive and motor impairment. AIM. To provide a literature review on the diagnosis, classification, and therapeutic approaches in patients with chronic cerebral ischemia. MATERIALS AND METHODS. A total of 25 literature sources were analyzed using the RSCI and PubMed databases covering the period from 2001 to 2025. The review included studies on diagnostic criteria, classification systems, and therapeutic strategies for chronic cerebral ischemia, with a focus on the use of nootropic and metabolic agents, including Russian clinical experience with carnitine chloride. CONCLUSION. The management of patients with chronic cerebral ischemia requires a comprehensive, evidence-based, and personalized approach that includes modification of risk factors, maintenance of perfusion stability, and long-term rehabilitation. Neurometabolic agents, including carnitine chloride, may serve as individualized adjuvant therapies that improve functional activity and quality of life; however, they do not replace fundamental vascular preventive measures. Future research should focus on refining chronic cerebral ischemia phenotypes and assessing the long-term efficacy of multimodal therapeutic strategies.

  • Diagnosis and Management of Diabetic Polyneuropathy: an Updated Algorithmic Approach. A Review

    by A.P. Rachin, S.A. Rachin, M.N. Sharov, R.R. Parsamyan, S.M. Karpov

    INTRODUCTION. Diabetic polyneuropathy is one of the most frequent and disabling complications of diabetes mellitus, exerting a profound impact on both life expectancy and quality of life. In the context of the rapidly increasing prevalence of diabetes worldwide and in Russia, the timely diagnosis and effective management of diabetic polyneuropathy have become an urgent clinical priority. AIM. To consider summarizes current concepts of pathogenesis, classification, diagnostic algorithms, and therapeutic strategies for diabetic polyneuropathy, emphasizing an interdisciplinary perspective. MAIN CONTENT OF THE REVIEW. Particular attention is given to the importance of early detection, which can be achieved through validated clinical scales such as the Neuropathy Symptom Score (NSS) and Total Symptom Score (TSS), as well as simple screening tools such as the Ipswich Touch Test. The integration of these instruments into routine practice contributes to the standardization of diagnostics and enables the objective assessment of symptom dynamics during treatment. The therapeutic section focuses on pathogenetically based approaches, with α-lipoic acid, B vitamins, and ipidacrine (Neiromidin®) playing a central role. Ipidacrine, in particular, has demonstrated efficacy in improving neuromuscular transmission, enhancing sensory function, and reducing pain severity, as supported by several clinical studies. CONCLUSION. The implementation of algorithm-based diagnostic and therapeutic approaches, the early use of pathogenetically targeted agents, and the development of personalized management strategies open new prospects for reducing the risk of severe complications and improving the quality of life in patients with diabetic polyneuropathy.

  • Open Access

    MEDICAL ASPECTS IN THE WORKS OF SALVADOR DALI: THROUGH THE PRISM OF PARANOIA AND ILLNESS

    by A Rachin, Mihail Sharov, Ruzanna Parsamyan, Sergey Rachin, Yuliya Prokof'EVa

    This article examines the influence of medical aspects, particularly paranoia and somatic illness, on Salvador Dali’s work. It analyses how the artist's personal experiences, his neurotic conditions and his scientific interests in medicine were reflected in his surrealist paintings. The study focuses on the symbolic interpretation of medical images and motifs in Dali’s works, and the relationship between his psychological state and artistic expression. It is emphasized that understanding the medical context of Dali’s work allows us to penetrate deeper into the meaning and content of his works, revealing new facets of his genius.

  • Back Pain Phenotypes from the Perspective of the New D-TIMER Concept: From Clinical Heterogeneity to Personalised Therapy

    by A.P. Rachin, M.N. Sharov, R.R. Parsamyan, S.A. Rachin, Yu.S. Prokofieva

    Back pain is a global public health problem characterised by high prevalence, significant economic burden and substantial impact on quality of life. Despite progress in understanding the pathophysiological aspects in the formation of back pain, the development of effective treatments remains a challenge. The traditional approach, which considers back pain as a single disease, does not take into account its inherent clinical heterogeneity. Back pain phenotyping, based on the identification of subgroups of patients with common clinical characteristics, pathophysiological mechanisms and prognosis, represents a promising approach to personalised diagnosis and therapy. This article provides an overview of the current state of research on back pain phenotypes, highlighting different approaches to their identification. The new concept of D-TIMER phenotyping of back pain and the prospects for its use in the development of new diagnostic and therapeutic strategies are presented.

  • Open Access

    Aspects of pharmaceutical care for patients with cephalgia in specialized neurology clinics

    by O. V. Reshetko, A. I. Grishin, R. R. Parsamyan, E. A. Rakhmanova

    Objective. To determine the characteristics of pharmaceutical care for patients with headache in specialized neurology clinics.Materials and methods. Questionnaire survey of clinic patients with the integrated ID–Migraine test using a validated questionnaire (from August to October 2023 inclusive) by a continuous sampling method, statistical processing of the results. Descriptive statistics and parametric and nonparametric methods were used in the statistical processing. The initially established level of statistical significance was considered to be at least 95 % at p Results. The study was conducted until 100 completed questionnaires were received. There was a high prevalence of women (84.0 %), mostly older than 40 years (68.1 %, n=94), and the average age of patients was 49.4±1.5 years. Migraine as a cause of headache was stated by 21.0 % of patients, and 38.9 % of patients answered positively to two or more questions of the ID–Migraine test (n=98), which may indicate the presence of migraine. Self-medication is widespread among patients (78.0 %), with 71.0 % considering it necessary to consult a physician only in case of prolonged headache that does not go away with analgesics. 63.0 % consider pharmacy as a specialized organization and pharmacists as highly qualified specialists who can qualitatively advise customers on drugs and symptoms, but should not diagnose and should not replace a physician (100.0 %). Also, the majority (72.0 %) believe that no pharmacist should be able to diagnose the type of headache based on symptoms and recommend drugs accordingly. Among the most important factors (on a 3‑point scale) influencing drug choice, clinic patients mentioned proven efficacy and safety (2.45±0.09), and prescribing physician (2.45±0.09). This indicates high compliance and trust of the clinic patients in the physician. The results of the questionnaire revealed three «profiles » of patients, the basis of which being fundamentally different attitudes toward pharmacists, pharmacies and physicians: neutral (loyal to pharmacies and pharmacists), highly loyal (to pharmacies and pharmacists), and loyal to the physician.Conclusion. Patients in clinics may be represented by different subgroups with specific characteristics, needs, preferences, and, accordingly, different strategies of pharmaceutical care. This highlights the need for an individualized approach to communication between the pharmacists and each patient, considering the specificity of their needs and expectations.

  • The Role of Central Sensitization and Disinhibition in the Maintenance of Chronic Back Pain: Focus on Myorelaxants. A Review

    by A.P. Rachin, A.V. Amelin, M.N. Sharov, R.R. Parsamyan, S.A. Rachin, Y.S. Prokofieva

    Chronic back pain (CBP) is a significant medical and social problem due to the complex interaction of peripheral and central mechanisms. This article is devoted to the analysis of the role of central sensitization and disinhibition in the pathogenesis of CPS, as well as to the rationale for the use of myorelaxants in the complex therapy of this condition. Central sensitization, characterized by increased excitability of neurons of the central nervous system, plays a key role in chronicity of pain syndrome. It results from prolonged nociceptive impulses, leading to changes in synaptic transmission and neuronal plasticity. Disinhibition, a decrease in the activity of inhibitory neuronal circuits, exacerbates central sensitization, contributing to increased pain perception and pain spread beyond the original focus. Myorelaxants, acting at different levels of the nervous system, help to reduce local muscle spasm, decrease pain impulsation and attenuate central sensitization. However, the efficacy and safety of different myorelaxants in CPS vary. The combination of mirtazapine (an antidepressant with analgesic properties) and tizanidine (a centrally acting myorelaxant) represents a promising approach to the complex effect on chronic pain mechanisms, modulating both central sensitization and disinhibition.


  • CUPOINTS - a New Model of chronic Pelvic Pain. The Place of Negative Childhood Experiences in the Formation of Primary Chronic Pelvic Pain Syndrome: а Review

    by M.N. Sharov, A.P. Rachin, M.YU. Maksimova, A.V. Zaitsev, Y.S. Prokofieva, S.A. Rachin, R.R. Parsamyan

    INTRODUCTION. For more than three decades, researchers have studied the relationship between the presence of chronic pain conditions and adverse childhood experiences (NCE) such as sexual abuse and family troubles. A number of intermittent hypotheses have been put forward to explain the relationship between chronic pain and the presence of adverse childhood care, mainly focusing on concepts of biological rooting. The (NCE) has been called a public health crisis, and it is widely recognized that it has a detrimental impact on social consequences and health conditions. AIM. To conduct a meta-analysis of the scientific evidence and to identify the place of negative childhood experiences in the in the development of primary chronic pelvic pain syndrome. MATERIALS AND METHODS. We performed meta-analyses on this topic in the following databases: PubMed, Research Gate, Elsevier in the time frame from 2015 to 2024. The following phrases were used to search for suitable literature: "chronic pelvic pain", "adverse childhood experience", "chronic pelvic pain syndrome", "endometriosis", "upoint", "upoints". DISCUSSION. Chronic pelvic pain syndrome is a rather ambiguous and multicomponent disease that includes a variety of pathophysiological mechanisms, and, unfortunately, currently the leading mechanism for the development of this syndrome has not been identified. The diagnosis of CFS is a diagnosis of exclusion, in which there is no infectious and/or organic pathology in the pelvic organs. However, in order to arrive at this diagnosis, it is necessary to undergo various examinations by doctors of various specialties: urologist, gynecologist, gastroenterologist, neurologist, psychotherapist, etc. An important component in the diagnosis of CFS and the development of further treatment tactics is the UPOINT(S) phenotyping model, which includes 7 domains: Urinary, Psychosocial, Organ specific, Infectious, Neurological/systemic and musculospastic skeletal muscles), an assessment of sexual activity function. Recent research reports on the need to introduce an eighth domain called "negative childhood experiences" into this concept and modify this model from UPOINTS to CUPOINTS. CONCLUSION. In our opinion, negative childhood experiences are one of the key links in the chain of proper diagnosis and treatment of pelvic pain syndromes, since it has become obvious that negative childhood experiences have a huge impact on the formation of chronic pain in general and chronic pain in particular.

  • Somatovegetative Disorders in General Practice: an Algorithm for General Practitioners. A Review

    by A.P. Rachin, T.N. Charnukha, E.N. Madjidova, S.T. Turuspekova, D.D. Turgumbaev, E.S. Nurguzhayev, A.T. Djurabekova, L.B. Novikova, L.S. Chutko, E.V. Ekusheva, et al.

    Somatovegetative disorders (SVR) represent a significant clinical problem characterized by a variety of symptoms and difficulty in diagnosis in general medical practice. This article is devoted to a detailed analysis of modern approaches to the diagnosis and therapy of SVR, focusing on the optimization of patient management in primary care. The paper considers key aspects of differential diagnosis of SVR, including the exclusion of organic pathology and identification of comorbid anxiety disorders. The importance of a comprehensive approach is emphasized, including assessment of the patient's somatic and mental status, as well as the use of validated scales and questionnaires to quantify the severity of symptoms. Special attention is paid to the pharmacotherapy of SVR, in particular, first-line drugs used for the treatment of anxiety disorders. The efficacy and safety of different groups of drugs, including selective serotonin reuptake inhibitors (SSRIs), selective serotonin and norepinephrine reuptake inhibitors (SSRIs) and anxiolytics, are analyzed. In the context of pharmacotherapy of SVR the feasibility of etifoxine (Anxilera) is considered in detail. The mechanisms of action of the drug, its efficacy in the treatment of anxiety and vegetative symptoms, as well as its safety profile in comparison with other anxiolytics are discussed. The data of clinical studies confirming the efficacy and tolerability of etifoxine in the treatment of SVR are presented. In conclusion, the article presents an algorithm of SVR therapy for general practitioners, which includes the stages of choosing the optimal pharmacotherapy taking into account the evaluation of treatment efficacy. The necessity of an integrative approach combining pharmacotherapy with psychotherapeutic methods and lifestyle modification is emphasized. The algorithm is designed to optimize the management of patients with SVR in primary care and improve their quality of life.


  • Open Access

    Wavelet-Detected Changes in Nocturnal Brain Electrical Activity in Patients with Non-Motor Disorders Indicative of Parkinson’s Disease

    by Anastasiya E. Runnova, Maksim O. Zhuravlev, Anton R. Kiselev, Ruzanna R. Parsamyan, Margarita A. Simonyan, Oxana M. Drapkina

    Background/Objectives—Parkinson’s disease (PD) is the second most common neurodegenerative disorder caused by the destruction of neurons in the substantia nigra of the brain. Clinical diagnosis of this disease, based on monitoring motor symptoms, often leads to a delayed start of PD therapy and control, where over 60% of dopaminergic nerve cells are damaged in the brain substantia nigra. The search for simple and stable characteristics of EEG recordings is a promising direction in the development of methods for diagnosing PD and methods for diagnosing the preclinical stage of PD development. Methods—42 subjects participated in work, of which 4 female/10 male patients were included in the group of patients with non-motor disorders, belonging to the risk group for developing PD (median age: 62 years, height: 164 cm, weight: 70 kg, pulse: 70, BPsys and BPdia: 143 and 80)/(median age: 68 years, height: 170 cm, weight: 73.9 kg, pulse: 75, BPsys and BPdia: 143 and 82). The first control group of healthy participants included 6 women (median age: 33 years, height: 161 cm, weight: 66 kg, pulse: 80, BPsys and BPdia: 110 and 80)/8 men (median age: 36.3 years, height: 175 cm, weight: 69 kg, pulse: 78, BPsys and BPdia: 120 and 85). The second control group of healthy participants included 8 women (median age: 74 years, height: 164 cm, weight: 70 kg, pulse: 70, BPsys and BPdia: 145 and 82)/6 men (median age: 51 years, height: 172 cm, weight: 72.5 kg, pulse: 74, BPsys and BPdia: 142 and 80). Wavelet oscillatory pattern estimation is performed on patients’ nocturnal sleep recordings without separating them into sleep stages. Results—Amplitude characteristics of oscillatory activity in patients without motor disorders and the prodromal PD stage are significantly reduced both in terms of changes in the number of patterns and in terms of their duration. This pattern is especially pronounced for high-frequency activity, in frequency ranges close to 40 Hz. Conclusions—The success of the analysis of the electrical activity of the brain, performed over the entire duration of the night recording, makes it promising to further use during daytime monitoring the concept of oscillatory wavelet patterns in patients with non-motor disorders, belonging to the risk group for developing PD. The daytime monitoring system can become the basis for developing screening tests to detect neurodegenerative diseases as part of routine medical examinations.